CEACAM5 and hepatocellular carcinoma: Increased CEA and AFP levels support the incidence of HCC in the control group of DEN/2AAF; this finding is consistent with Gokuladhas et al. (2015), who reported that DEN induced an increase in HCC biomarkers.